PT Merck Tbk (MERK.JK)
IDR 3490.0
(-0.29%)
IDR 3490.0
(-0.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 961.43 Billion IDR | -14.51% |
| 2022 | 1124.59 Billion IDR | 5.66% |
| 2021 | 1064.39 Billion IDR | 62.29% |
| 2020 | 655.84 Billion IDR | -11.92% |
| 2019 | 744.63 Billion IDR | 21.68% |
| 2018 | 611.95 Billion IDR | -47.09% |
| 2017 | 1156.64 Billion IDR | 11.77% |
| 2016 | 1034.8 Billion IDR | 5.22% |
| 2015 | 983.44 Billion IDR | 13.93% |
| 2014 | 863.2 Billion IDR | -27.7% |
| 2013 | 1193.95 Billion IDR | 28.4% |
| 2012 | 929.87 Billion IDR | 1.24% |
| 2011 | 918.53 Billion IDR | 15.44% |
| 2010 | 795.68 Billion IDR | 5.89% |
| 2009 | 751.4 Billion IDR | 17.93% |
| 2008 | 637.13 Billion IDR | 16.43% |
| 2007 | 547.23 Billion IDR | 12.23% |
| 2006 | 487.6 Billion IDR | 26.21% |
| 2005 | 386.34 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 282.53 Billion IDR | 27.43% |
| 2024 Q2 | 221.7 Billion IDR | -11.14% |
| 2024 Q1 | 249.49 Billion IDR | 37.93% |
| 2023 FY | 961.43 Billion IDR | -14.51% |
| 2023 Q4 | 180.88 Billion IDR | -35.94% |
| 2023 Q3 | 282.34 Billion IDR | 19.09% |
| 2023 Q2 | 237.07 Billion IDR | -9.21% |
| 2023 Q1 | 261.13 Billion IDR | 2.26% |
| 2022 Q3 | 269.67 Billion IDR | -9.51% |
| 2022 Q2 | 298 Billion IDR | -1.18% |
| 2022 Q1 | 301.56 Billion IDR | 8.36% |
| 2022 FY | 1124.59 Billion IDR | 5.66% |
| 2022 Q4 | 255.36 Billion IDR | -5.31% |
| 2021 FY | 1064.39 Billion IDR | 62.29% |
| 2021 Q1 | 253.36 Billion IDR | 17.28% |
| 2021 Q2 | 253.47 Billion IDR | 0.04% |
| 2021 Q3 | 279.25 Billion IDR | 10.17% |
| 2021 Q4 | 278.31 Billion IDR | -0.34% |
| 2020 FY | 655.84 Billion IDR | -11.92% |
| 2020 Q2 | 120.59 Billion IDR | -25.67% |
| 2020 Q4 | 216.02 Billion IDR | 37.61% |
| 2020 Q1 | 162.24 Billion IDR | -34.22% |
| 2020 Q3 | 156.98 Billion IDR | 30.18% |
| 2019 FY | 744.63 Billion IDR | 21.68% |
| 2019 Q1 | 163.16 Billion IDR | 152.95% |
| 2019 Q2 | 153.62 Billion IDR | -5.84% |
| 2019 Q3 | 181.18 Billion IDR | 17.94% |
| 2019 Q4 | 246.65 Billion IDR | 36.13% |
| 2018 Q3 | 314.15 Billion IDR | 6.63% |
| 2018 Q2 | 294.61 Billion IDR | -5.37% |
| 2018 FY | 611.95 Billion IDR | -47.09% |
| 2018 Q1 | 311.33 Billion IDR | 20.5% |
| 2018 Q4 | -308.15 Billion IDR | -198.09% |
| 2017 Q2 | 290.14 Billion IDR | -8.28% |
| 2017 FY | 1156.64 Billion IDR | 11.77% |
| 2017 Q4 | 258.37 Billion IDR | -11.46% |
| 2017 Q3 | 291.79 Billion IDR | 0.57% |
| 2017 Q1 | 316.33 Billion IDR | 39.06% |
| 2016 FY | 1034.8 Billion IDR | 5.22% |
| 2016 Q1 | 305.96 Billion IDR | 33.52% |
| 2016 Q2 | 272 Billion IDR | -11.1% |
| 2016 Q3 | 229.36 Billion IDR | -15.67% |
| 2016 Q4 | 227.47 Billion IDR | -0.83% |
| 2015 Q1 | 270.72 Billion IDR | 408.99% |
| 2015 Q2 | 258.92 Billion IDR | -4.36% |
| 2015 Q3 | 224.64 Billion IDR | -13.24% |
| 2015 Q4 | 229.14 Billion IDR | 2.01% |
| 2015 FY | 983.44 Billion IDR | 13.93% |
| 2014 FY | 863.2 Billion IDR | -27.7% |
| 2014 Q1 | 324.71 Billion IDR | 19.29% |
| 2014 Q2 | 327.41 Billion IDR | 0.83% |
| 2014 Q4 | -87.61 Billion IDR | -129.33% |
| 2014 Q3 | 298.68 Billion IDR | -8.77% |
| 2013 FY | 1193.95 Billion IDR | 28.4% |
| 2013 Q4 | 272.2 Billion IDR | 0.92% |
| 2013 Q3 | 269.72 Billion IDR | -8.52% |
| 2013 Q2 | 294.83 Billion IDR | -17.45% |
| 2013 Q1 | 357.17 Billion IDR | 81.38% |
| 2012 Q2 | 260.48 Billion IDR | 12.16% |
| 2012 Q4 | 196.91 Billion IDR | -18.03% |
| 2012 FY | 929.87 Billion IDR | 1.24% |
| 2012 Q1 | 232.25 Billion IDR | 7.8% |
| 2012 Q3 | 240.22 Billion IDR | -7.78% |
| 2011 FY | 918.53 Billion IDR | 15.44% |
| 2011 Q3 | 226.39 Billion IDR | -5.54% |
| 2011 Q2 | 239.66 Billion IDR | 1.11% |
| 2011 Q1 | 237.02 Billion IDR | 12.29% |
| 2011 Q4 | 215.44 Billion IDR | -4.84% |
| 2010 Q4 | 211.07 Billion IDR | 0.0% |
| 2010 FY | 795.68 Billion IDR | 5.89% |
| 2010 Q1 | 196.62 Billion IDR | -11.51% |
| 2009 FY | 751.4 Billion IDR | 17.93% |
| 2009 Q4 | 222.2 Billion IDR | 0.0% |
| 2009 Q1 | 166.1 Billion IDR | 0.0% |
| 2008 FY | 637.13 Billion IDR | 16.43% |
| 2007 FY | 547.23 Billion IDR | 12.23% |
| 2006 FY | 487.6 Billion IDR | 26.21% |
| 2005 FY | 386.34 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1890.88 Billion IDR | 49.154% |
| PT Phapros, Tbk | 1014.12 Billion IDR | 5.196% |
| PT Pyridam Farma Tbk | 702.06 Billion IDR | -36.943% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3565.93 Billion IDR | 73.038% |
| PT Tempo Scan Pacific Tbk | 13119.78 Billion IDR | 92.672% |